Michail Sideris, Consultant Gynaecologist and Gynaecological Oncology Surgeon at The London Clinic, shared on LinkedIn:
“Six Decades of Pelvic Exenterative Surgery for Gynaecological Malignancies’ is one of the largest meta-analyses on this topic, synthesising 132 studies published between 1964 and 2024, covering 13,434 women across 29 countries.
Pelvic exenteration (PE) remains one of the most radical procedures in gynaecological oncology, offering a chance of cure for carefully selected women with advanced or recurrent pelvic disease. Yet robust international data to guide counselling and decision-making have been limited.
Pelvic exenteration remains one of the most radical procedures in gynaecological oncology, offering a chance of cure for selected women with advanced or recurrent pelvic disease. We provide contemporary pooled estimates of indications, surgical intent, morbidity, perioperative mortality and margin status. Cervical cancer was the leading indication (61%), followed by uterine and vulval cancers (13% each).
Very grateful to International Institute of Anticancer Research and IV journal for their opportunity to present our work there
Other articles from Michail Sideris on OncoDaily.